1. Choi SH, Kim KH, Song KH. Clinical features of cutaneous premalignant lesions in Busan city and the Eastern Gyeongnam province, Korea: a retrospective review of 1,292 cases over 19 years (1995~2013). Ann Dermatol. 2016; 28:172–178. PMID:
27081263.
Article
2. Järup L. Hazards of heavy metal contamination. Br Med Bull. 2003; 68:167–182. PMID:
14757716.
Article
3. Uddin AN, Burns FJ, Rossman TG, Chen H, Kluz T, Costa M. Dietary chromium and nickel enhance UV-carcinogenesis in skin of hairless mice. Toxicol Appl Pharmacol. 2007; 221:329–338. PMID:
17499830.
Article
4. Surdu S, Fitzgerald EF, Bloom MS, Boscoe FP, Carpenter DO, Haase RF, et al. Occupational exposure to arsenic and risk of nonmelanoma skin cancer in a multinational European study. Int J Cancer. 2013; 133:2182–2191. PMID:
23595521.
Article
5. World Health Organization. International Agency for Research on Cancer. Cadmium and cadmium compounds. World Health Organization. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 58. Beryllium, cadmium, mercury, and exposures in the glass manufacturing industry. Lyon: IARC Press;1993. p. 119–237.
6. World Health Organization. International Agency for Research on Cancer. Summary of data reported and evaluation. World Health Organization. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 87. Inorganic and organic lead compounds. Lyon: IARC Press;2006. p. 370–378.
7. Kim YD, Eom SY, Yim DH, Kim IS, Won HK, Park CH, et al. Environmental exposure to arsenic, lead, and cadmium in people living near Janghang copper smelter in Korea. J Korean Med Sci. 2016; 31:489–496. PMID:
27051230.
Article
8. Hong YS, Song KH, Chung JY. Health effects of chronic arsenic exposure. J Prev Med Public Health. 2014; 47:245–252. PMID:
25284195.
Article
9. Rossman TG. Mechanism of arsenic carcinogenesis: an integrated approach. Mutat Res. 2003; 533:37–65. PMID:
14643412.
Article